Literature DB >> 11812783

Mechanisms of regulation of phospholipase D1 and D2 by the heterotrimeric G proteins G13 and Gq.

Zhi Xie1, Wan-Ting Ho, Rachel Spellman, Songmin Cai, John H Exton.   

Abstract

Our earlier studies of rat brain phospholipase D1 (rPLD1) showed that the enzyme could be activated in cells by alpha subunits of the heterotrimeric G proteins G(13) and G(q). Recently, we showed that rPLD1 is modified by Ser/Thr phosphorylation and palmitoylation. In this study, we first investigated the roles of these post-translational modifications on the activation of rPLD1 by constitutively active Galpha(13)Q226L and Galpha(q)Q209L. Mutations of Cys(240) and Cys(241) of rPLD1, which abolish both post-translational modifications, did not affect the ability of either Galpha(13)Q226L or Galpha(q)Q209L to activate rPLD1. However, the RhoA-insensitive mutants, rPLD1(K946A,K962A) and rPLD1(K962Q), were not activated by Galpha(13)Q226L, although these mutant enzymes responded to phorbol ester and Galpha(q)Q209L. On the contrary, the PKC-insensitive mutant rPLD1(DeltaN168), which lacks the first 168 amino acids of rPLD1, responded to Galpha(13)Q226L but not to Galpha(q)Q209L. In addition, we found that rPLD2 was strongly activated by Galpha(q)Q209L and phorbol ester. However, surprisingly, the enzymatic activity of rPLD2 was suppressed by Galpha(13)Q226L and constitutively active V14RhoA in COS-7 cells. Abolition of the post-translational modifications of rPLD2 did not alter the effects of Galpha(q)Q209L or Galpha(13)Q226L. The suppressive effect of Galpha(13)Q226L on rPLD2 was reversed by dominant negative N19RhoA and the C3 exoenzyme of Clostridium botulinum, further supporting a role for RhoA. In summary, Galpha(13) activation of rPLD1 in COS-7 cells is mediated by Rho, while Galpha(q) activation requires PKC. rPLD2 is activated by Galpha(q), but is inhibited by Galpha(13). Neither Ser/Thr phosphorylation nor palmitoylation is required for these effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812783     DOI: 10.1074/jbc.M109751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

2.  Involvement of vasodilator-stimulated phosphoprotein in UDP-induced microglial actin aggregation via PKC- and Rho-dependent pathways.

Authors:  Ayako Kataoka; Yui Koga; Ayumi Uesugi; Hidetoshi Tozaki-Saitoh; Makoto Tsuda; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2011-05-13       Impact factor: 3.765

Review 3.  Revisited and revised: is RhoA always a villain in cardiac pathophysiology?

Authors:  Shigeki Miyamoto; Dominic P Del Re; Sunny Y Xiang; Xia Zhao; Geir Florholmen; Joan Heller Brown
Journal:  J Cardiovasc Transl Res       Date:  2010-05-27       Impact factor: 4.132

Review 4.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 5.  Phospholipase D signaling: orchestration by PIP2 and small GTPases.

Authors:  Paschal A Oude Weernink; Maider López de Jesús; Martina Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-24       Impact factor: 3.000

Review 6.  Lysophospholipid receptor activation of RhoA and lipid signaling pathways.

Authors:  Sunny Yang Xiang; Stephanie S Dusaban; Joan Heller Brown
Journal:  Biochim Biophys Acta       Date:  2012-09-15

7.  GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors.

Authors:  Bin Zheng; Christopher P Berrie; Daniela Corda; Marilyn G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

Review 8.  Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Authors:  Danielle Kamato; Lyna Thach; Rebekah Bernard; Vincent Chan; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Narin Osman; Peter J Little
Journal:  Front Cardiovasc Med       Date:  2015-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.